April 25 – 27, 2023 | Boston, MA
2022 was another great year for cell engager antibody therapies, and since the approval of Tecytinib, 2023 looks like it will be the year for cell engagers!
The 5th Cell Engager Summit returns to Boston as the only industry-led meeting bringing together 80+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference workshops to delve into the biggest challenges cell engager therapeutics face. Breaking into the solid tumor, preventing CRS and maximizing the quality of insights we gain from preclinical modeling.
Join your colleagues, including our Bispecific Research Lead, Shailee Patel, at the most comprehensive cell engager event, leaving no stone unturned, this highly focused meeting covers everything translational and clinical in greater depth and detail than any before it.